Searchable abstracts of presentations at key conferences in endocrinology

ea0056p639 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Optimization of the use of outpatient diabetes center through a coordinated task force between primary care and endocrinology unit

Belen Ojeda Schuldt Maria , Mateo Gavira Isabel , Sanchez Lechuga Begona , Larran Escandon Laura , Roca Rodriguez Mar , Zarallo Perez Antonio , Aguilar Diosdado Manuel

Objetives: To analyze the profile of patients referred from Primary Care (PC) to Outpatient Diabetes Center (ODC), as well as the evolution of self-assessment measured by Chronic Care Model IEMAC (Instrument for the Evaluation of Attention Chronicity Models) tool after implementation of a coordinated Task Force between Primary Care and Endocrinology Unit.Methods: The working group of the Advanced Diabetes Center in Cádiz-San Fernando Sanitary Area w...

ea0056p1167 | Thyroid cancer | ECE2018

TSH level and risk of malignancy in patients with thyroid nodules with Bethesda IV Cytopathology System

Moujir Carolina Fernandez-Trujillo , Perez Carlos Antonio Rodriguez , Arencibia Dunia Marrero , Plasencia Yaiza Lopez , Zaballo Julio Perez , Galvan Jose Cabrera , Mogollon Francisco Javier Novoa , Cortes Mauro Boronat

Introduction: Fine needle aspiration biopsy (FNAB) is the mainstay diagnostic procedure for evaluation of thyroid nodules, but it doesn’t permit to distinguish between benign and malignant follicular lesions (category IV in the Bethesda Cytopathology System). Some reports have suggested an association between increased serum levels of TSH and thyroid cancer. However, the specific relationship between TSH and malignancy has been scarcely studied in follicu...

ea0037gp.14.07 | Diabetes and obesity – Clinical diabetes | ECE2015

Degree of control of type 2 diabetes in Spain according to individualised glycaemic targets

Minambres Inka , Mediavilla Jose Javier , Gonzalez-Segura Diego , Perez Antonio

Our objective was to estimate the distribution of Spanish diabetic patients attending to individualized glycaemic targets recommended by the ADA/EASD consensus with and without considering hypoglycaemia risk. We conducted a cross-sectional study in a Spanish primary care setting between 2011 and 2012. A total of 5382 type 2 diabetic subjects under antihyperglycaemic treatment for at least 3 months prior to inclusion completed a study visit in which clinical data including age,...

ea0056p499 | Diabetes therapy | ECE2018

Metabolic effects of liraglutide in type 2 diabetic patients.

Muros Mariola Mendez , Portillo Cristobal Morales , Hermosilla Antonio Manuel Garrido , Septimo Vianney Magaly Santiago , Perez Antonio Perez , Margalet Victor Sanchez , Brocca Maria Asuncion Martinez

Objectives: Obesity and type 2 diabetes mellitus (DM2) are risk factors for non-alcoholic fatty liver disease (NAFLD). The main objective was to study the incidence of NAFLD using the Hepatic Steatosis Index (HSI) in obese patients with DM2. Secondary objectives were to analyse the effect of liraglutide over HSI, body mass index (BMI) and glycated hemoglobin (HbA1c).Methods: Retrospective observational study of obese type 2 diabetic patients treated with...

ea0026p555 | Cardiovascular endocrinology and lipid metabolism | ECE2011

Polycystic ovary syndrome and their relationship with metabolic syndrome in female-to-male transsexuals

Becerra Antonio , Lopez Gilberto Perez , Menacho Miriam , Molina Jose Miguel Rodriguez , Lucio M Jesus , Asenjo Nuria

Objective: To determine the prevalence of polycystic ovary syndrome (PCOS) and hyperandrogenism and their relationships with metabolic syndrome (MS) parameters in female-to-male transsexuals (FMT).Design and methods: Seventy-seven FMT were assessed clinically and biochemically to hyperandrogenism, before the beginning of the treatment with testosterone. We also assessed cardiovascular risk factors and other parameters of MS.Results...

ea0026p689 | Diabetes complications | ECE2011

Study of endothelial dysfunction in diabetes. assesment of ANP leves in patients without vascular disease

Vicente Maria Rosa Villar , De Villar Noemi Gonzalez Perez , Hernando Carmen Alameda , Fernandez Antonio Becerra

Background: Endothelial dysfunction may have deleterious effect cardiovascular pathology in diabetic patients.Atrial natriuretic peptide (ANP) exerts beneficial effects on the cardiovascular system in part by exerting antioxidant activity. Recently it was reported that ANP is able to exert an antihypertrophic effect in myocitos at least in part due to inhibition of NADPH oxidase and superoxido generation.It seems that hyperglucemia...

ea0022p565 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Daily temozolomide therapy in Nelson's syndrome

Ortiga Ruth Sanchez , Sanchez Victor L Gonzalez , Perez Oscar Moreno , Meana Andres , Alfonso Antonio A Pico

Temozolomide, an alkylating agent used in malignant gliomas, has been recently used too in the treatment of aggressive pituitary tumors. To date, two cases of Nelson’s syndrome has successfully treated with 5 days of 28-day cycle, but the follow-up has been shorter than 12 months. We reported the third patient with Nelson’s syndrome treated with temozolomide, who after an initial goal response to three 300 mg 5 days of 28-day cycles shown a clinical and biochemical (...

ea0035p186 | Cardiovascular Endocrinology &amp; Lipid Metabolism | ECE2014

Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals

Becerra-Fernandez Antonio , Menacho-Roman Miriam , Perez-Lopez Gilberto , Lucio-Perez Maria Jesus , Asenjo-Araque Nuria , Rodriguez-Molina Jose Miguel , Villar-Vicente Maria Rosa

Prevalence of hyperandrogenism (HA) and polycystic ovary syndrome (PCOS) in female to male transsexuals (FMT) is controversial. To known the prevalence of hyperandrogenism and PCOS in FMT, and their relation with insulin resistance (IR) and other cardiovascular risk factors (CVRF), we studied 77 Spanish consecutive FMT cases, the first ones who appeared in our Gender Unit between May 2007 and Dec 2008, aged 18–43 years. The subjects had never received hormonal treatment o...

ea0032p431 | Diabetes | ECE2013

Relationship between endothelin-1 levels in diabetics with and without microangiopathy and control subjects

Vicente Maria Rosa Villar , Alameda Carmen , Becerra Antonio , Menacho Miriam , Lopez Gilberto Perez , de Villar Noemi G Perez , Rodriguez Azucena , Cancer Emilia , Canovas Gloria

Aim: To assess ET1 levels in diabetic patients with and without microangiopathy, and compared with normal subjects, nondiabetic, without underlying vascular pathology.Introduction: The pathophysiology of diabetic microangiopathy is complex and many important aspects of it still are not fully understood. Endothelial dysfunction is of major importance in the pathogenesis of atherosclerosis and diabetic angiopathy. ET-1 is one of the most potent vasoconstri...

ea0022p136 | Cardiovascular endocrinology and lipid metabolism | ECE2010

Serum ferritin and risk of the metabolic syndrome in cross-sex hormone-treated transsexuals

Fernandez Antonio Becerra , Lopez Gilberto Perez , Menacho Miriam , Lucio Perez Maria Jesus , Araque Nuria Asenjo , Rodriguez Molina Jose Miguel , Llopis Agelan Jose Luis

Moderately elevated body iron stores may be associated with several components of the metabolic syndrome (MetSyn). Elevated serum ferritin levels (Fer) independently predicted incident type 2 diabetes in prospective studies in apparently healthy men and women.Aims: To analyze the association between Fer and components of MetSyn in transsexuals before and after 2-year cross-sex treatment (CST).Methods: Before starting the CST in 90 ...